Medicine and Dentistry
Patient
100%
Diabetes
51%
Association
48%
Diastolic Dysfunction
41%
Cardiovascular System
36%
Biological Marker
34%
Cardiovascular Disease
33%
Age
32%
Follow up
22%
Diet and Cancer
22%
Maturity Onset Diabetes of the Young
21%
Syndrome
19%
Mortality
19%
Myocardial Infarction
17%
Metabolic Syndrome
17%
Brain Natriuretic Peptide
16%
Male
16%
Heart Ventricle Remodeling
16%
Woman
16%
Adult
15%
Heart Failure with Preserved Ejection Fraction
14%
Hazard Ratio
14%
Man
14%
Therapeutic Procedure
13%
Chronic Kidney Disease
13%
Intima-Media Thickness
13%
Apoplexy
13%
Prospective Cohort Study
13%
Faintness
13%
Hypertension
12%
Protein
12%
Odds Ratio
12%
Examination
12%
Ejection Fraction
11%
Proportional Hazards Model
11%
Glomerular Filtration Rate
11%
Diastolic Function
11%
Atrial Fibrillation
11%
Stress
10%
Blood
10%
Echocardiography
10%
Indicator
10%
Hospital
10%
Middle Age
9%
Population
9%
Atherosclerosis
9%
Observational Study
9%
Gastric Inhibitory Polypeptide
8%
Prognosis
8%
Plaque
8%
Biochemistry, Genetics and Molecular Biology
N-Terminus
55%
Metabolite
44%
Protein
43%
Natriuretic Peptide
42%
Brain Natriuretic Peptide
29%
Proteomics
22%
Galectin
19%
Standing
17%
Glucose
17%
Phenotype
16%
Pulse Wave
16%
Metabolomics
15%
Atrial Fibrillation
14%
Genetic Divergence
14%
Atrial Natriuretic Peptide
13%
Amino Acids
13%
Selenoprotein P
13%
Cholesterol
12%
Magnetism
12%
Blood Pressure
12%
Glucose Blood Level
11%
Volume
11%
Glutamine
10%
Mendelian Randomization
10%
Human
10%
Heart Ejection Fraction
9%
Tissue Oxygenation
9%
Metabolic Pathway
8%
Allele
8%
Cognition
8%
Spectroscopy
8%
Triglyceride
8%
Eicosanoid Receptor
8%
Physical Activity
7%
Mouse Model
7%
Gene
7%
HDL-Cholesterol
7%
Fat
7%
Mediator
7%
Infrared Spectroscopy
7%
MMP2
6%
Normal Human
6%
Longevity
6%
Prospective Study
6%
Morphology
6%
Monocyte
6%
Genetic Determinism
6%
Single-Nucleotide Polymorphism
6%
Proteome
6%
Prospective Cohort Study
6%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
43%
Cardiovascular Disease
37%
Malignant Neoplasm
24%
Non Insulin Dependent Diabetes Mellitus
20%
Glucose
18%
Metabolic Syndrome X
17%
Prognosis
14%
Heart Infarction
10%
Heart Muscle Fibrosis
7%
Obesity
7%
2 Aminoadipic Acid
6%
Atrial Natriuretic Factor
6%
Taurocholic Acid
6%
Heart Failure with Preserved Ejection Fraction
6%
Heart Failure with Reduced Ejection Fraction
6%
Fat
6%
Hormone Precursor
6%
Beta Adrenergic Receptor Blocking Agent
6%
Monocytosis
6%
Mild Renal Impairment
6%
Glutamine
6%
Prospective Study
6%
Antibodies
6%
Cathepsin D
5%
Cohort Study
5%
